FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077668 [Registered on: 04/12/2024] Trial Registered Prospectively
Last Modified On: 03/12/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   EFFECTIVENESS OF VIRTUAL REALITY TRAINING ON HAND MOVEMENTS AMONG STROKE PATIENTS WITH PARALYSIS 
Scientific Title of Study   EFFECTIVENESS OF IMMERSIVE VIRTUAL REALITY TRAINING ON HAND MOTOR FUNCTION AMONG HEMIPARETICS 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  VISHNU PRIYA M 
Designation  ASSISTANT PROFESSOR 
Affiliation  SATHYABAMA INSTITUTE OF SCIENCE AND TECHNOLOGY 
Address  DEPARTMENT OF PHYSIOTHERAPY, DENTAL BLOCK, SATHYABAMA INSTITUTE OF SCIENCE AND TECHNOLOGY, JEPPIAR NAGAR, SH 49 A, CHENNAI, TAMIL NADU 600119
Jeppiaar Nagar, SH 49A, Chennai, Tamil Nadu 600119
Chennai
TAMIL NADU
600119
India 
Phone  08148967036  
Fax    
Email  priyavishnu835@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  VISHNU PRIYA M 
Designation  ASSISTANT PROFESSOR 
Affiliation  SATHYABAMA INSTITUTE OF SCIENCE AND TECHNOLOGY 
Address  Department of Physiotherapy, Sathyabama Institute of Science and Technology, Jeppiaar Nagar, SH 49A, Chennai, Tamil Nadu 600119

Chennai
TAMIL NADU
600119
India 
Phone  08148967036  
Fax    
Email  priyavishnu835@gmail.com  
 
Details of Contact Person
Public Query
 
Name  VISHNU PRIYA M 
Designation  ASSISTANT PROFESSOR 
Affiliation  SATHYABAMA INSTITUTE OF SCIENCE AND TECHNOLOGY 
Address  Jeppiaar Nagar, SH 49A, Chennai, Tamil Nadu 600119

Chennai
TAMIL NADU
600119
India 
Phone  08148967036  
Fax    
Email  priyavishnu835@gmail.com  
 
Source of Monetary or Material Support  
SATHYABAMA INSTITUTE OF SCIENCE AND TECHNOLOGY- INSTITUTIONAL SEED FUND, JEPPIAR NAGAR, CHENNAI - 600119, TAMIL NADU, INDIA. 
 
Primary Sponsor  
Name  SATHYABAMA INSTITUTE OF SCIENCE AND TECHNOLOGY 
Address  Jeppiaar Nagar, SH 49A, Chennai, Tamil Nadu, INDIA 600119 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR PRIYA KUMARI HOD  SATHYABAMA HOSPITAL  Physiotherapy Out patient department, First floor, Sathyabama Institute of Science and Technology, Jeppiaar Nagar, SH 49A, Chennai, Tamil Nadu 600119
Chennai
TAMIL NADU 
9789807079

priyakumari.physiotherapy@sathyabama.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
VELS INSTITUTE OF SCIENCE AND TECHNOLOGY - INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G819||Hemiplegia, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  CONVENTIONAL PHYSIOTHERAPY INTERVENTION FOR HAND FUNCTION  REGULAR PHYSIOTHERAPY REHABILITATION GIVEN BY DIFFERENT FUNCTIONAL ACTIVITIES 
Intervention  IMMERSIVE VIRTUAL REALITY TRAINING FOR HAND MOTOR FUNCTION  USING THE DESIGNED GAMING APPLICATION "SYNAPSE VR" - PATIENTS ARE IMMERSED INTO VIRTUAL REALITY ENVIRONMENT BY WEARING VR GOGGLES. SET OF 12 GAME ACTIVITIES ARE GIVEN TO IMPROVE HAND MOVEMENTS 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Acute to subacute stroke more than one month of onset to six months
Hemiparetic subjects - Ischemic 0r hemorrhage stroke
Conscious and comprehensive MMSE – 24- 30
Educational level – Basic qualification

 
 
ExclusionCriteria 
Details  Multiple infarcts or hemorrhage
Cognitive impairment
Vertigo
Motion sickness
Other neurological, visual, musculoskeletal conditions
Sensory problems
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Post test – fugyl meyer assessment UE Hand component
2.Box and block test
 
1st measure - BASELINE
2nd measure - AFTER 6 WEEKS
3rd measure - after follow up of 12 weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
BDNF - BRAIN DERIVED NEUROTROPHIC FACTOR  8.0–927.0pg per ml 
 
Target Sample Size   Total Sample Size="76"
Sample Size from India="76" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  17/02/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Virtual reality training is one of the advanced form of rehabilitation. Immersion into unrealistic environment provides various sensory feedback. The synapse VR application designed to improve hand motor function among hemiparetic patients. The activities are believed to facilitate the hand motor function. 
Hemiparetic subjects will be recruited based upon inclusion and exclusion criteria and randomly allocated into two groups. Informed consent will be obtained. participants are assigned and evaluated for the outcome measures. Group A receives Immersive virtual reality intervention and group B receives conventional rehabilitation exercise program for 6 weeks and follow up measures were taken after 12 weeks. 
 
Close